Proactive Investors - Run By Investors For Investors

Botanix Pharmaceuticals Ltd attracts investment from its own chairman

Botanix listed on the ASX in July 2016 by way of reverse takeover.
Botanix Pharmaceuticals Ltd attracts investment from its own chairman
Graham Griffiths, chairman, recently purchased 1 million shares.

Botanix Pharmaceuticals Ltd (ASX:BOT) recently saw 1 million shares purchased on market by its very own chairman – Graham Griffiths.

Botanix is a medical dermatology company developing treatments for serious skin diseases and its board and management own over 23% of the company.

One such skin disease is acne, affecting 50 million people creating a market valued near $3 billion.

By harnessing the ingredient cannabidiol, Botanix is preparing for the first human trials utilising its proprietary drug Permetrex™.

The company recently presented at the 7th Annual Australian Microcap Investment Conference where it exhibited why it might have the holy grail of acne treatments.

Botanix listed on the ASX in July 2016 by way of reverse takeover – shares are now trading more than double the prospectus offering price of $0.02.

View full . profile View Profile

Proactive Investors Australia Timeline

Related Articles

Bloomsbury Publishing
March 19 2019
Peel Hunt expects “superior returns" from the firm’s investment in digital capacity
Students in a class
August 27 2018
The company is gaining traction in Asia where people are looking to take language courses to work or study internationally
marketing
January 30 2019
“With the geopolitical landscape remaining in flux, clients are looking for greater certainty from their marketing programmes which our agencies and data businesses are proving able to provide"

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use